1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Profile Solutions, Inc.

Profile Solutions, Inc.

PSIQ
Profile Solutions, Inc.US flagOther OTC
0.00
USD
- -
- -
38,829.00Market Cap
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
TTM
Revenue per Share
0.04
0.01
- -
- -
- -
- -
- -
Basic EPS, GAAP
0.02
- -
-0.01
-0.01
-0.01
-0.01
-0.01
Free Cash Flow per Basic Share
0.01
0.01
-0.01
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
-0.01
-0.02
-0.02
-0.03
-0.03
Tangible Book Value per Share
0.02
0.02
- -
-0.01
-0.02
-0.02
-0.03
Basic Weighted Avg Shares
- -
2
5
5
5
5
5
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
46.11
29.01
-431.41
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
6.91
- -
- -
- -
- -
- -
Profit Margin (%)
46.11
27.01
-438.46
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
25.01
- -
- -
- -
- -
- -
Return on Capital (%)
- -
162.65
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'10
Mar'11
Jun'11
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Dec'10
Mar'11
Jun'11
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
160.29%
38.41%
Free Cash Flow
- -
-87.25%
9.21%
Net Income, GAAP
- -
-195.04%
22.02%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
-0.01
2010
- -
- -
- -
- -
-0.01
2011
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Dan Oran
Full Time Employees
5
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
8411 West Oakland Park Boulevard Sunrise FL United States of America 33351
IPO Date
Nov 21, 2007
Website
profilesolutionsinc.com
Similar Companies
Dynavax Technologies Corporation (DVAX)
Simply Better Brands Corp. (SBBC.V)
Terra Tech Corp. (TRTC)
Gridiron BioNutrients, Inc. (GMVP)
CannaPharmaRX, Inc. (CPMD)
Zhejiang NHU Company Ltd. (002001.SZ)
Business
Profile Solutions, Inc. (PSIQ) manufactures and distributes cannabinoid hemp extracts through its subsidiary Elite Products International, Inc.; core products include edibles such as candies, gummies, cookies, crystal pops, honey, and multi-vitamins; oils and tinctures; vapes; creams and salves for humans; and specialized creams and salves for house pets. The company operates in the pharmaceuticals and biotech sector, focusing on drug manufacturers specializing in generic and specialty products derived from industrial hemp; it targets consumer markets for wellness and pet care products. Founded in 2006 and headquartered in Sunrise, Florida, at 8411 West Oakland Park Boulevard, Profile Solutions conducts its primary operations in the United States with historical interests in international hemp cultivation ventures. No major acquisitions, partnerships, funding rounds, or strategic shifts have been publicly announced for Profile Solutions in the last one to two years as of December 2025; the company maintains a minimal operational footprint with five employees and trailing twelve-month revenue of approximately $770,000, reflecting ongoing challenges in the competitive CBD market. Recent financial metrics indicate net losses of around $276,000 over the past year, with a microcap market capitalization under $1,000 and shares trading at negligible levels on the OTC Pink market under ticker PSIQ.